185 related articles for article (PubMed ID: 11544946)
1. [Rediscovery of thalidomide. Successful treatment of discoid lupus erythematosus].
Kuhn A; Hefter H; Ruzicka T; Lehmann P
Hautarzt; 2001 Aug; 52(8):726-33. PubMed ID: 11544946
[TBL] [Abstract][Full Text] [Related]
2. Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome.
Zhang L; Au S; Aronson IK
Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526013
[TBL] [Abstract][Full Text] [Related]
3. Clinical-therapeutic study on the efficacy and safety of thalidomide in the management of discoid lupus erythematosus. A single-centre, retrospective study.
Tirado-Sánchez A; Aguilar-Mena C; Rodriguez-Mendoza A; Hernández-Salgado Y; Bonifaz A
Australas J Dermatol; 2021 Aug; 62(3):375-379. PubMed ID: 33729544
[TBL] [Abstract][Full Text] [Related]
4. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.
Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
J Am Acad Dermatol; 1996 Dec; 35(6):969-79. PubMed ID: 8959957
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms.
Domingo S; Solé C; Moliné T; Ferrer B; Ordi-Ros J; Cortés-Hernández J
Dermatology; 2020; 236(5):467-476. PubMed ID: 32659758
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide for treatment of severe generalized discoid lupus lesions in two patients with systemic lupus erythematosus.
Alfadley A; Al-Rayes H; Hussein W; Al-Dalaan A; Al-Aboud K
J Am Acad Dermatol; 2003 May; 48(5 Suppl):S89-91. PubMed ID: 12734488
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide in cutaneous lupus erythematosus.
Pelle MT; Werth VP
Am J Clin Dermatol; 2003; 4(6):379-87. PubMed ID: 12762830
[TBL] [Abstract][Full Text] [Related]
8. Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients.
Coelho A; Souto MI; Cardoso CR; Salgado DR; Schmal TR; Waddington Cruz M; de Souza Papi JA
Lupus; 2005; 14(6):434-9. PubMed ID: 16038106
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide and its impact in dermatology.
Stirling DI
Semin Cutan Med Surg; 1998 Dec; 17(4):231-42. PubMed ID: 9859910
[TBL] [Abstract][Full Text] [Related]
10. Chronic cutaneous lupus erythematosus. Thalidomide treatment of 11 patients.
Hasper MF
Arch Dermatol; 1983 Oct; 119(10):812-5. PubMed ID: 6614949
[TBL] [Abstract][Full Text] [Related]
11. Dermatologic and nondermatologic uses of thalidomide.
Nasca MR; Micali G; Cheigh NH; West LE; West DP
Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
Ordi-Ros J; Cortés F; Cucurull E; Mauri M; Buján S; Vilardell M
J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide: dermatological indications, mechanisms of action and side-effects.
Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide: a review of approved and investigational uses.
Matthews SJ; McCoy C
Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503
[TBL] [Abstract][Full Text] [Related]
15. [Thalidomide therapy for discoid lupus erythematosus].
Lyakhovisky A; Baum S; Shpiro D; Salomon M; Trau H
Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
[TBL] [Abstract][Full Text] [Related]
16. Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus.
Kyriakis KP; Kontochristopoulos GJ; Panteleos DN
Int J Dermatol; 2000 Mar; 39(3):218-22. PubMed ID: 10759967
[TBL] [Abstract][Full Text] [Related]
17. [Thalidomide and thrombosis].
Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
Cortés-Hernández J; Torres-Salido M; Castro-Marrero J; Vilardell-Tarres M; Ordi-Ros J
Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
[TBL] [Abstract][Full Text] [Related]
19. Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus.
Thomson KF; Goodfield MJ
J Dermatolog Treat; 2001 Sep; 12(3):145-7. PubMed ID: 12243705
[TBL] [Abstract][Full Text] [Related]
20. [Thalidomide in the treatment of chronic discoid lupus erythematosus].
Brocard A; Barbarot S; Milpied B; Stalder JF
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):853-6. PubMed ID: 16327714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
